Supplemental products used for weight loss

Journal of the American Pharmacists Association

Volumn 44, Issue 1, 2004, Pages 59-68

  Lenz, Thomas L ^a   Hamilton, William R ^a  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dietary supplements; Herbal products; Obesity; Overweight; Weight loss

Indexed keywords

PLANT MEDICINAL PRODUCT;

CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG EFFECT; HUMAN; OBESITY; PHYTOTHERAPY; REVIEW; WEIGHT REDUCTION;

CLINICAL TRIALS; DIETARY SUPPLEMENTS; HUMANS; OBESITY; PHYTOTHERAPY; PLANT PREPARATIONS; WEIGHT LOSS;

EID: 1442283813     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/154434504322713246     Document Type: Review

References (34)

1. Berke EM, Morden NE. Medical management of obesity. Am Fam Physician. 2000;62:419-26.
2. Yanovski SZ, Yanovski JA. Obesity. N Engl J Med. 2002;346:591-602.
3. Makdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. JAMA. 2003;289:76-9.
4. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in adults. Bethesda, Md.: National Institutes of Health, U.S. Dept of Health and Human Services; 1998. NIH publication 98-4083.
5. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion. Behavioral Risk Factor Surveillance System. http://apps.nccd.cdc.gov/brfss/page.asp?yr=2000&state=us&cat= wc#wc. Accessed December 11, 2003.
6. Jellin JM, Gregory P, Batz F, et al. Pharmacist's Letter/Prescriber's Letter Natural medicines comprehensive database. 3rd ed. Stockton, Calif.: Therapeutic Research Faculty; 2000: 271-463.
7. DeLany JP, West DB. Changes in body composition with conjugated linoleic acid. J Am Coll Nutr. 2000;19:487S-493S.
8. Pariza MW, Yeonhwa P, Cook ME. Conjugated linoleic acid and the control of cancer and obesity. Toxicol Sci. 1999;52 (2 suppl):107-10.
9. Blankson H, Stakkestad JA, Fagertun H, et al. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr. 2000;130:2943-8.
10. Riserus U, Berglund L, Vessby B. Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of metabolic syndrome: a randomized controlled trial. Int J Obes Relat Metab Disord. 2001;25:1129-35.
11. Smedman A, Vessby B. Conjugated linoleic acid supplementation in humans - metabolic effects. Lipids. 2001;36:773-81.
12. Holzman D. The ephedra controversy. Alt Complement Ther. 1999;5:335-6.
13. Shekelle PG, Hardy ML, Morton SC, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA. 2003;289:1537-45.
14. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000;343:1833-8.
15. Bent S, Tiedt TN, Odden MC, Shlipak MG. The relative safety of ephedra compared with other herbal products. Ann Intern Med. 2003;138:468-71.
16. Anderson RA. Effects of chromium on body composition and weight loss. Nutr Rev. 1998;56:266-70.
17. Lukaski HC. Chromium as a supplement. Annu Rev Nutr. 1999;19:279-302.
18. Grant KE, Chandler RM, Castle AL, Ivy JL. Chromium and exercise training: effect on obese women. Med Sci Sports Exerc. 1997;29:992-8.
19. Trent LK, Thieding-Cancel D. Effects of chromium picolinate on body composition. J Sports Med Phys Fitness. 1995;35:273-80.
20. Kaats GR, Blum K, Fisher JA. Effects of chromium picolinate supplementation on body composition: a randomized, double-masked placebo controlled study. Curr Ther Res. 1996;57:747-56.
21. Bahadori B, Wallner S, Schneider H, et al. Effect of chromium yeast and chromium picolinate on body composition of obese, non-diabetic patients during and after a formula diet [German]. Acta Med Austriaca. 1997;24:185-7.
22. Morelli V, Zoorob RJ. Alternative therapies. Part I: depression, diabetes, obesity. Am Fam Physician. 2000;62:1051-60.
23. Sullivan AC, Triscari J, Hamilton JG, Miller ON. Effect of (-) hydroxycitrate upon the accumulation of lipid in the rat. Lipids. 1973;9:129-34.
24. Nageswara Rao R, Sakeriak KK. Lipid-lowering and anti-obesity effect of (-) hydroxycitric acid. Nutr Res. 1988;8:209-12.
25. Heymsfield SB, Allison DB, Vasselli JR, et al. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent. JAMA. 1998;280:1596-1600.
26. Pittler MH, Abbot NC, Harkness EF, Ernst E. Randomized, double-blind trial of chitosan for body weight reduction. Eur J Clin Nutr. 1999;53:379-81.
27. Schiller RN, Barrager E, Schauss AG, Nichols EJ. Randomized, double-blind, placebo controlled study examining the effects of a rapidly soluble chitosan dietary supplement on weight loss and body composition in overweight and mildly obese individuals. Chin Pharm J (Taiwan). 2001;4:42-9.
28. Allison DB, Fontaine KR, Heshka S, et al. Alternative treatments for weight loss: a critical review. Crit Rev Food Sci Nutr. 2001;41:1-28.
29. Stanko RT, Tietze DL, Arch JE. Body composition, energy utilization, and nitrogen metabolism with a severely restricted diet supplemented with dihydroxyacetone and pyruvate. Am J Clin Nutr. 1992;55:771-6.
30. Stanko RT, Tietze DL, Arch JE. Body composition, energy utilization, and nitrogen metabolism with a 4.25-MJ/d low-energy diet supplemented with pyruvate. Am J Clin Nutr. 1992;56:630-5.
31. Stanko RT, Arch JE. Inhibition of regain in body weight and fat with addition of 3-carbon compounds to the diet with hyperenergetic refeeding after weight reduction. Int J Obes Relat Metab Disord. 1996:20:925-30.
32. Kalman D, Colker CM, Stark R, et al. Effect of pyruvate supplementation on body composition in mood. Cur Ther Res. 1998;59:793-802.
33. Kalman D, Colker CM, Wilets I, et al. The effects of pyruvate supplementation on body composition in overweight individuals. Nutrition. 1999;15:337-40.
34. Blanck HM, Khan LK, Serdula MK. Use of nonprescription weight loss products: results from a multistate survey. JAMA. 2001;286:930-5.